Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report

Claus F. Vogelmeier, Gerard J. Criner, Fernando J. Martinez, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Rongchang Chen, Marc Decramer, Leonardo M. Fabbri, Peter Frith, David M.G. Halpin, M. Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D. Sin, Dave Singh, Robert Stockley, Jørgen VestboJadwiga A. Wedzicha, Alvar Agustí

Research output: Contribution to journalReview articlepeer-review

1350 Scopus citations

Abstract

This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention ofCOPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.

Original languageEnglish (US)
Pages (from-to)557-582
Number of pages26
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume195
Issue number5
DOIs
StatePublished - Mar 1 2017

Keywords

  • COPD diagnosis
  • COPD management
  • COPD prevention
  • Chronic obstructive pulmonary disease

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report'. Together they form a unique fingerprint.

Cite this